Large Scale Screening of Fragile X Syndrome in Newborn Babies Possible

by Kathy Jones on  December 25, 2012 at 7:35 PM Genetics & Stem Cells News
RSS Email Print This Page Comment
A new study published in the journal Genome Medicine reveals that the number of babies who carry the form of a gene FMR1 is higher than previously thought and large scale screening for fragile X syndrome in newborns can be undertaken successfully.
 Large Scale Screening of Fragile X Syndrome in Newborn Babies Possible
Large Scale Screening of Fragile X Syndrome in Newborn Babies Possible
Advertisement

Three large hospitals in the USA participated in this study, testing more than 14,000 newborns, including children of different ethnic backgrounds. While only one child was identified with the full mutation, the team led by Dr Flora Tassone from UC Davis found that the prevalence of the premutation was higher than previously suggested, particularly for males (one in 209 females and one in 430 males).

Advertisement
Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability and autism, or autism spectrum disorder, and is caused by mutations in the gene FMR1. The mutation which causes FXS is not actually in the gene but is due to the addition of extra CGG repeats in the promoter region that controls whether the gene is switched on or off.

The full mutation of more than 200 CGG repeats prevents proper functioning of the gene and causes FXS, while premutation (55 to 200 repeats) means that the baby has a higher chance of having a child with FXS, and has an increased risk child and adult-onset disorders such as neurological complications. The impact of so called 'grey zone allele' (45 to 54 repeats) on health is currently not as clear, and is the focus of ongoing research. However, the team also found that the Caucasian group had a higher prevalence of grey zone alleles than the Hispanic and African American groups.

Dr Tassone from UC Davis who led this study explains, "Our study shows that screening newborns for FXS can be done, but we will also identify carrier and grey zone babies as well as those with a full mutation. Before newborn screening for fragile X mutations is expanded nationally, we need to better understand the impact that identification of the premutation and grey zone allele has on families and systems will need to be in place to address the counseling and educational needs that inevitably will arise."



Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Turner Syndrome Fragile X Syndrome Ehlers-Danlos syndrome 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive